Sustainability & Climate

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

Haffner Energy launches its C-iC modular line, aiming to slash project costs and make mid-sized biofuel and hydrogen production financially viable without subsidies.

Roche's CT-388 posts impressive Phase II results, positioning it as a powerful new rival to Zepbound and Wegovy in the booming obesity drug market.

A stunning New Year's show with 500 drones and fireworks at a luxury hotel signals a new era of high-tech, experiential tourism in Japan.

With 43M downloads and tens of millions in revenue, bootstrapped Polyverse Studio is quietly reshaping AI creativity, rivaling tech giants on the app charts.

With DOE safety validation for its Mark-0 reactor, Antares accelerates its push to power U.S. defense and space missions with advanced nuclear energy.

A clean energy firm is pushing thorium micro-reactors for ships, promising zero emissions. But can it navigate the waters of regulation and public fear?

FHLBank San Francisco's major 2025 investment aims to tackle housing shortages in AZ, CA, and NV, but is it enough to turn the tide?

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

Medallion's new line, shaped by pro feedback, blends architectural style with smart function, redefining the 'art of living well' for modern homes.

Fresh analyst coverage signals a potential rebirth for the med-tech firm after a major financial restructuring. But why do experts disagree on its value?

A new partnership between OneBill and linked2pay promises to eliminate billing complexity, offering a unified platform for merchants and new revenue for ISOs.

Nord Anglia Education empowers students to solve real-world problems, from building prosthetics to restoring coral reefs, through a unique metacognitive approach.

A new company plans to race uncrewed spacecraft in orbit by 2028, promising a new era of sport and innovation. But can it navigate the cosmic hurdles?

New study shows oral weight loss drug QSYMIA, paired with digital tech, delivers major results, offering a cheaper alternative to pricey injectables.

As US organ donor registrations fall, Southern Legacy of Life achieves its second-best year, saving hundreds through strategic community engagement.

A groundbreaking survey by Bluebella reveals women now buy lingerie for confidence and self-worth, challenging the industry's focus on romance.

ePIC's new 1.5% firmware fee for its UMC OS democratizes elite mining tools, forcing a rethink of profitability and challenging hardware reliance.

A new report reveals a strategic shift from pandemic chaos to stable, worker-centric benefits, with financial wellness and flexibility now leading the way.

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.